Holen Sie sich die Stockscreener-App
0.3788
3.54%
-0.0139
Handel nachbörslich:
.36
-0.0188
-4.96%
Schlusskurs vom Vortag:
$0.3927
Offen:
$0.3928
24-Stunden-Volumen:
14.80M
Relative Volume:
1.60
Marktkapitalisierung:
$19.07M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.53M
KGV:
-0.0786
EPS:
-4.82
Netto-Cashflow:
$-11.12M
1W Leistung:
+77.67%
1M Leistung:
+97.70%
6M Leistung:
+45.69%
1J Leistung:
-69.94%
1-Tages-Spanne:
$0.3171
$0.438
1-Wochen-Bereich:
$0.2076
$0.5697
52-Wochen-Spanne:
$0.15
$1.50
Processa Pharmaceuticals Inc Stock (PCSA) Company Profile
Firmenname
Processa Pharmaceuticals Inc
Sektor
Branche
Telefon
443-776-3133
Adresse
601 21ST STREET, SUITE 300, VERO BEACH
Vergleichen Sie PCSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
0.3788 | 21.92M | 0 | -11.53M | -11.12M | -4.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-25 | Eingeleitet | H.C. Wainwright | Buy |
Processa Pharmaceuticals Inc Aktie (PCSA) Neueste Nachrichten
Using AI based signals to follow Processa Pharmaceuticals Inc.Market Weekly Review & Momentum Based Trading Ideas - newser.com
Can swing trading help recover from Processa Pharmaceuticals Inc. lossesJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com
Live market analysis of Processa Pharmaceuticals Inc.Trade Performance Summary & AI Forecast for Swing Trade Picks - newser.com
Forecasting Processa Pharmaceuticals Inc. price range with options dataWeekly Profit Analysis & Weekly High Momentum Picks - newser.com
Top chart patterns to watch in Processa Pharmaceuticals Inc.2025 Year in Review & Risk Managed Investment Entry Signals - newser.com
Is Processa Pharmaceuticals Inc. stock a buy before product launches2025 Momentum Check & Safe Capital Preservation Plans - newser.com
Using economic indicators to assess Processa Pharmaceuticals Inc. potentialQuarterly Profit Summary & Weekly Watchlist of Top Performers - newser.com
Is Processa Pharmaceuticals Inc. still worth holding after the dipQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - newser.com
Is Processa Pharmaceuticals Inc. stock a defensive play in 2025July 2025 Spike Watch & Capital Protection Trading Alerts - newser.com
How Processa Pharmaceuticals Inc. stock reacts to inflationary pressures2025 Momentum Check & Free Expert Verified Stock Movement Alerts - newser.com
Why Processa Pharmaceuticals Stock Rose Almost 38% Overnight? - Benzinga
Biotech Stocks Surge After Hours: PCSA, PALI, And QTTB Lead On Volume And Speculation - Nasdaq
TELO, PCSA, RVPH, NMTC, BRTX Jump In After-Hours Trading On Light News Flow And Select Updates - RTTNews
Momentum divergence signals in Processa Pharmaceuticals Inc. chart2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com
Published on: 2025-10-05 04:03:55 - newser.com
Can machine learning forecast Processa Pharmaceuticals Inc. recovery2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com
Published on: 2025-10-03 04:24:10 - newser.com
Published on: 2025-10-03 02:09:35 - newser.com
Processa Pharmaceuticals' chief business officer buys $34,691 in stock - MSN
Ulcerated Necrobiosis Lipoidica Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Processa Pharmaceuticals - The Globe and Mail
Strategies to average down on Processa Pharmaceuticals Inc.Quarterly Trade Review & Daily Growth Stock Investment Tips - newser.com
Published on: 2025-09-29 04:18:13 - newser.com
Published on: 2025-09-29 03:25:55 - newser.com
What analysts say about Processa Pharmaceuticals Inc stockVolume Analysis Techniques & Minimal Investment Trading - earlytimes.in
What drives Processa Pharmaceuticals Inc stock priceStock Correlation Metrics & Exceptional Profit Growth Tips - earlytimes.in
Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Processa Pharmaceuticals Inc-Aktie (PCSA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ng George K | Chief Executive Officer |
Jan 27 '25 |
Buy |
0.80 |
87,200 |
69,542 |
87,200 |
| Young David | Pres. Research & Development |
Jan 27 '25 |
Buy |
0.80 |
124,500 |
99,289 |
205,405 |
| Lin Patrick | Chief Business - Strategy Off |
Jan 27 '25 |
Buy |
0.80 |
43,500 |
34,691 |
43,500 |
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):